Healthcare investor Frazier Life Sciences has sealed a $1.3bn final close for its latest flagship fund, which will target company creation and early-stage private biopharmaceutical business.

Tech and healthcare-focused growth equity firm Silversmith Capital Partners has continued its breakneck fundraising pace by collecting $1.7bn for its new flagship fund - its fifth in the last ten ...

CSP Associates, a leading M&A advisory firm known for its expertise in aerospace, defense, and government services, today ...

Skyline Investors, a LA-based firm specialising in investments to strengthen local economies, has closed its inaugural fund ...